3D Microfluidic Cell Culture Market Size, Share, By Component, Application, End User and Region- Trends, Analysis and Forecast till 2035
Description
The 3D microfluidic cell culture represents an advanced technique that mimics the physiological environment of tissues more accurately than traditional 2D cultures. The focused market is experiencing significant growth due to the increasing demand for advanced cell based research tools. The target market include a variety of microfluidic devices designed for different cell culture applications, which range from organ-on-chip systems to personalized medicine platforms.
3D Microfluidic Cell Culture Market Report Highlights:
Advantages and Disadvantages of Hydrogels for Cell Culture Applications:
Hydrogels are three-dimensional networks made of several natural and synthetic polymers that imitate the extracellular matrix's natural environment by retaining water through swelling up to 90%.
Based on the source of the polymer that makes them up, hydrogels can be divided into two main groups: natural and synthetic monomers. Agarose, chitosan, alginate, collagen, dextran, fibrin, Matrigel, laminin, silk fibroin, and hyaluronic acid (HA) are examples of natural or biological hydrogels utilised in microfluidic cell culture applications.
Poly-Ethylene Glycol (PEG), Poly (Ethylene Glycol) Diacrylate (PEG-DA), 2-Hydroxyethyl Methacrylate (2-HEMA), Poly-2-Hydroxyethyl Methacrylate (PHEMA), Poly-L-Lactic Acid (PLLA), Poly-Lactic-co-Glycolic Acid (PLGA), Poly-Glycerol Sebacate (PGS), and PuraMatrixTM, a fully synthetic peptide-based polymer, have also been utilised in conjunction with microfluidics. PEG and its derivatives are the most often used hydrogel among them for applications involving microfluidic cell culture.
Browse ∼45 market data tables and ∼47 figures through ∼171 slides and in-depth TOC on “3D Microfluidic Cell Culture Market Size, Share, By Component, Application, End User and Region- Trends, Analysis, and Forecast till 2035”
Competitive Landscape of 3D Microfluidic Cell Culture Market:
The prominent players competing in the 3D microfluidic cell culture market are Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Lonza, Avantor, Inc., REPROCELL Inc., InSphero AG, MIMETAS B.V., CureMetrix, Tecan Trading AG, Emulate, Inc., Cellink, Greiner Bio-One International GmbH, Kirkstall Ltd., and Synthecon, Inc.
Segmentation:
By Component:
3D Microfluidic Cell Culture Market Report Highlights:
- In 2024, the 3D microfluidic cell culture market size was worth USD 114.2 million.
- By 2035, the target market is expected to reach a size of USD 448.4 million.
- The market is expected to grow at a CAGR of 16.2%.
- North America is set to hold the largest market share with 42.5%.
- Asia Pacific is projected to be the fastest-growing market in the coming years
- By component, the 3D microfluidic devices segment is anticipated to dominate the market during the forecast period.
- On the basis of application, the drug discovery segment holds the largest market share.
- By end-user, the pharmaceutical & biotechnology companies segment is leading the market.
- In October 2024, Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about how these cancers develop and grow. However, the research team found something incredible that could lead to a new way to treat not just breast and prostate cancers but all cancers.
- In July 2023, Lonza has launched the TheraPRO CHO Media System, a new cell culture platform that simplifies processes and optimizes productivity and protein quality when used with GS-CHO cell lines. The launch supports pharmaceutical and biotechnology companies manufacturing therapeutic proteins to further improve product quality while streamlining time-to-market.
Advantages and Disadvantages of Hydrogels for Cell Culture Applications:
Hydrogels are three-dimensional networks made of several natural and synthetic polymers that imitate the extracellular matrix's natural environment by retaining water through swelling up to 90%.
Based on the source of the polymer that makes them up, hydrogels can be divided into two main groups: natural and synthetic monomers. Agarose, chitosan, alginate, collagen, dextran, fibrin, Matrigel, laminin, silk fibroin, and hyaluronic acid (HA) are examples of natural or biological hydrogels utilised in microfluidic cell culture applications.
Poly-Ethylene Glycol (PEG), Poly (Ethylene Glycol) Diacrylate (PEG-DA), 2-Hydroxyethyl Methacrylate (2-HEMA), Poly-2-Hydroxyethyl Methacrylate (PHEMA), Poly-L-Lactic Acid (PLLA), Poly-Lactic-co-Glycolic Acid (PLGA), Poly-Glycerol Sebacate (PGS), and PuraMatrixTM, a fully synthetic peptide-based polymer, have also been utilised in conjunction with microfluidics. PEG and its derivatives are the most often used hydrogel among them for applications involving microfluidic cell culture.
Browse ∼45 market data tables and ∼47 figures through ∼171 slides and in-depth TOC on “3D Microfluidic Cell Culture Market Size, Share, By Component, Application, End User and Region- Trends, Analysis, and Forecast till 2035”
Competitive Landscape of 3D Microfluidic Cell Culture Market:
The prominent players competing in the 3D microfluidic cell culture market are Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Lonza, Avantor, Inc., REPROCELL Inc., InSphero AG, MIMETAS B.V., CureMetrix, Tecan Trading AG, Emulate, Inc., Cellink, Greiner Bio-One International GmbH, Kirkstall Ltd., and Synthecon, Inc.
Segmentation:
By Component:
- 3D Microfluidic Devices
- Consumables
- Media
- Reagents
- Others
- Others
- Drug Discovery
- Organ-on-a-Chip
- Toxicology Testing
- Disease Modeling
- Tissue Engineering
- Regenerative Medicine
- Cancer Research
- Stem Cell Research
- Others
- Hospitals & Diagnostic Centers
- Contract Research Organizations (CROs)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
171 Pages
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Component
- Market Snippet, By Application
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Fabrication of a 3D microfluidic cell culture device for bone marrow-on-a-chip
- Regulatory Framework
- Overview for Microfluidics-based 3D Cell Culture Models
- Market Segmentation, By Component, Forecast Period up to 10 Years, (USD Mn)
- Overview
- Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- 3D Microfluidic Devices
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Consumables
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Media
- Reagents
- Others
- Others
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Mn)
- Overview
- Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Drug Discovery
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Organ-on-a-Chip
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Toxicology Testing
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Disease Modeling
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Tissue Engineering
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Regenerative Medicine
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cancer Research
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Stem Cell Research
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End-User, Forecast Period up to 10 Years, (USD Mn)
- Overview
- Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals & Diagnostic Centers
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contract Research Organizations (CROs)
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Academic & Research Institutes
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Mn)
- Overview
- Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Mn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Asia Pacific
- Market Size and Forecast (USD Mn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Mn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherland
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Mn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Market Size and Forecast (USD Mn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East and Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Corning Incorporated
- Lonza
- Avantor, Inc.
- REPROCELL Inc.
- InSphero AG
- MIMETAS B.V.
- CureMetrix
- Tecan Trading AG
- Emulate, Inc.
- Cellink
- Greiner Bio-One International GmbH
- Kirkstall Ltd.
- Synthecon, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
